Among the studies for Covid-19, which has become one of the biggest global problems of recent years, studies were continuing to develop a drug that would prevent the symptoms of the disease. Pfizer’s Covid pill Paxlovid has been approved by the European Medicines Agency.
The coronavirus pandemic has affected the whole world and its effects continue to be felt. The measures taken so far have been aimed at preventing the spread of the disease. Until now for emergencies only The use of a drug used for the treatment of Covid was authorized by the European Medicines Agency.
German pharmaceutical giant Pfizer developed by Paxlovid medicine before American Food and Drug Administration (FDA) It was authorized for use in emergencies. This pill helps people who come into contact with the disease be treated before their condition worsens and they develop serious symptoms.
Pfizer relies on its own pill
Especially Omicron variant With this, the treatment of coronavirus came to the point of blockage once again. Because the two antibiotics that were effective in the previous variants were quite ineffective this time. Thanks to the confirmation at this time the pandemic getting out of control again One more step has been taken to prevent it.
Pfizer’s Paxlovid The reasons why this medicine is considered so important are its efficiency, relatively low cost and ease of authorization. The test results of the drug are also remarkable. The drug, which prevents the virus from replicating and multiplying, reduces the risk of being hospitalized and death by 89%.
RELATED NEWS
Urgent Use Permit Requested for World’s First COVID-19 Pill
RELATED NEWS
Pfizer-BioNTech Announces Developing More Effective Vaccine Against Omicron: Provides Higher Immunity Than Original Vaccine
Pfizer is ready for production
RELATED NEWS
Frightening Statement from Bill Gates: A New Pandemic Process Is Inevitable
Pfizer has previously traded in the US for this drug. 10 million doses agreed to pay $5.29 billion in this deal. In the statement made by Pfizer at the end of last year, it was also stated that the United Kingdom 2.5 million doses It was announced that additional supply would be provided. The first agreed amount was 250 thousand doses.
Geoffrey Porges, SVB Leerink analyst $24.2 billion He said he expected a turnover. Pfizer CEO Bourla said that the company will Production of 80 million doses He said he could do it. The drug, which was previously approved for emergency, is now available in Europe.